1.Four new sesquiterpenoids from the roots of Atractylodes macrocephala 
		                			
		                			Gang-gang ZHOU ; Jia-jia LIU ; Ji-qiong WANG ; Hui LIU ; Zhi-Hua LIAO ; Guo-wei WANG ; Min CHEN ; Fan-cheng MENG
Acta Pharmaceutica Sinica 2025;60(1):179-184
		                        		
		                        			
		                        			 The chemical constituents in dried roots of 
		                        		
		                        	
2.Spatial epidemiological analysis of severe hand, foot and mouth disease in Guangxi, 2014-2018
PENG Yuan-jun ; HE Wei-tao ; ZHENG Zhi-gang ; PAN Pei-jiang ; JU Yu ; LU Zhen-wei ; LIAO Yan-yan
China Tropical Medicine 2023;23(5):473-
		                        		
		                        			
		                        			Abstract:  Objective To explore the spatial epidemiological characteristics of severe cases hand, foot and mouth disease (HFMD) in Guangxi, China, from 2014 to 2018, and to provide a basis for identifying the high-risk regions as well as the prevention and control of severe cases of HFMD in Guangxi. Methods Spatial-temporal scanning analysis, global and local spatial autocorrelation analysis were used to analyze the spatial clustering of HFMD. The trend surface analysis was used to evaluate the spatial distribution trend of HFMD. Results From 2014 to 2018, the incidence and severe case fatality rates of HFMD were 3.89/100 000 and 4.23%, respectively. Monte Carlo scanning analysis showed that the first cluster region was Cenxi City, the second cluster was mainly concentrated in northwest of Guangxi, and the aggregation time was mainly concentrated in April to May and August to October. The global spatial autocorrelation analysis showed that the severe HFMD was significant clustering distribution, and the Moran's I coefficients of the sever cases, severe morbidity and severe case fatality rate were 0.088, 0.118, 0.197, respectively (P<0.05). Local spatial autocorrelation analysis showed that hotspots of severe HFMD cases were concentrated in the southern Guangxi, mainly in Lingshan County. Anselin local Moran's I clustering and outlier analysis indicated that 5 high-high (H-H) clustering regions for fatality were Lingshan, Pubei, Zhongshan, Zhaoping and Pinggui County. There were 6 high-high (H-H) clustering regions for severe incidence rate, namely Lingshan, Qinnan, Lingyun, Youjiang, Bama Yao Autonomous and Pinggui County, and 1 high-low (H-L) clustering region, Cenxi County. The trend surface analysis showed that the overall number of severe cases of death decreased from east or west to the middle, and increased from north to middle, and then decreased to south. Conclusions Severe HFMD cases in Guangxi have obvious spatial-temporal clustering, and the hop spots are mainly concentrated in southern Guangxi. The prevention and control of HFMD in areas with high incidence of severe cases should be strengthened to reduce the burden of HFMD cases.
		                        		
		                        		
		                        		
		                        	
3.Effects of Differential First-Line Antiretroviral Therapy (ART) Regimens on Mortality among HIV/AIDS Children in Southwest China: A 15-year Retrospective Cohort Study.
Qiu Li CHEN ; Yan Yan LIAO ; Shan Fang QIN ; Chun Yan LU ; Pei Jiang PAN ; Hai Long WANG ; Jun Jun JIANG ; Zhi Gang ZHENG ; Feng Xiang QIN ; Wen HONG ; Chuan Yi NING ; Li YE ; Hao LIANG
Biomedical and Environmental Sciences 2023;36(11):1079-1083
4.Advances in epigenetics in ischemic stroke.
Dan-Hong LIU ; Xia-Jun XIONG ; Jun LIAO ; Zhi-Gang MEI ; Jin-Wen GE ; Meng-Zhen WEI
China Journal of Chinese Materia Medica 2022;47(17):4551-4559
		                        		
		                        			
		                        			Ischemic stroke is one of the main causes of death and long-term disability worldwide, which seriously affects the quality of life of patients and brings a heavy economic burden to families and society. Epidemiological studies have shown that stroke has become the second leading cause of death and major disabling disease in the world, with the characteristics of high morbidity, high recurrence, and high mortality. Epigenetic mechanism is the molecular process where gene expression and function in each cell are dynamically regulated and interconnected and a biological mechanism that changes genetic performance without changing the DNA sequence, including DNA methylation, histone modifications, and non-coding RNA. However, the research on epigenetics is currently focused on other diseases such as tumors. Recent studies have found that epigenetics has received extensive attention in the past few decades as a key factor involved in the pathophysiological process of ischemic stroke. The present study introduced the mediation of epigenetics in the induction of stroke, summarized the potential drug targets for these mechanisms in the treatment of stroke, and further explored the significance of traditional Chinese medicine(TCM) against cerebral ischemia injury based on TCM classification of stroke.
		                        		
		                        		
		                        		
		                        			DNA Methylation
		                        			;
		                        		
		                        			Epigenesis, Genetic
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Ischemic Stroke/genetics*
		                        			;
		                        		
		                        			Quality of Life
		                        			;
		                        		
		                        			RNA, Untranslated/metabolism*
		                        			;
		                        		
		                        			Stroke/genetics*
		                        			
		                        		
		                        	
5.Neurological Diseases Responding Specifically to Traditional Chinese Medicine
Ling-bo KONG ; Shu-yan WANG ; Xiao-ling LIAO ; Li ZHOU ; Ke-gang CAO ; Zhi-peng YU ; Huan-qin LI ; Geng LI ; Chao-yang HUANG ; Xi-yan XIN ; Zhi-chen ZHANG ; Wang-shu XU ; Da-yong MA ; Xiao-xiao ZHANG ; Ying GAO
Chinese Journal of Experimental Traditional Medical Formulae 2021;27(13):172-178
		                        		
		                        			
		                        			In recent years, the incidence of neurological diseases has been increasing year by year. To give full play to the advantages of traditional Chinese medicine (TCM) in the treatment of neurological disorders, identify the breakthrough point of integrating TCM with western medicine, and further standardize the clinical diagnosis and treatment of TCM, the China Association of Chinese Medicine organized neurologists in TCM and western medicine to carry out in-depth discussion on the neurological diseases responding specifically to TCM and integrated TCM and western medicine, such as stroke, headache, vertigo, multiple sclerosis, and epilepsy, aiming to formulate a well-recognized and integrated treatment protocol for TCM and western medicine and improve the efficacy of neurological disorders. Furthermore, the treatment suggestions of the corresponding diseases in TCM and western medicine were proposed to provide references for clinical practice and scientific research.
		                        		
		                        		
		                        		
		                        	
6.Advance in mechanisms of glial scarring after stroke and intervention of traditional Chinese medicine.
Ji-Yong LIU ; Jun LIAO ; Rui FANG ; Jin-Wen GE ; Zhi-Gang MEI
China Journal of Chinese Materia Medica 2021;46(23):6139-6148
		                        		
		                        			
		                        			When ischemia or hemorrhagic stroke occurs, astrocytes are activated by a variety of endogenous regulatory factors to become reactive astrocytes. Subsequently, reactive astrocytes proliferate, differentiate, and migrate around the lesion to form glial scar with the participation of microglia, neuron-glial antigen 2(NG2) glial cells, and extracellular matrix. The role of glial scars at different stages of stroke injury is different. At the middle and late stages of the injury, the secreted chondroitin sulfate proteoglycan and chondroitin sulfate are the main blockers of axon regeneration and nerve function recovery. Targeted regulation of glial scars is an important pathway for neurological rehabilitation after stroke. Chinese medicine has been verified to be effective in stroke rehabilitation in clinical practice, possibly because it has the functions of promoting blood resupply, anti-inflammation, anti-oxidative stress, inhibiting cell proliferation and differentiation, and benign intervention in glial scars. This study reviewed the pathological process and signaling mechanisms of glial scarring after stroke, as well as the intervention of traditional Chinese medicine upon glial scar, aiming to provide theoretical reference and research evidence for developing Chinese medicine against stroke in view of targeting glial scarring.
		                        		
		                        		
		                        		
		                        			Astrocytes
		                        			;
		                        		
		                        			Axons/pathology*
		                        			;
		                        		
		                        			Cicatrix/pathology*
		                        			;
		                        		
		                        			Gliosis/pathology*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Medicine, Chinese Traditional
		                        			;
		                        		
		                        			Nerve Regeneration
		                        			;
		                        		
		                        			Stroke/drug therapy*
		                        			
		                        		
		                        	
7.Multidisciplinary team model for patients with oral cancer and systemic diseases: an expert consensus.
Dong-Sheng ZHANG ; Jia-Wei ZHENG ; Chen-Ping ZHANG ; Zhi-Gang CAI ; Long-Jiang LI ; Gui-Qing LIAO ; Zheng-Jun SHANG ; Mo-Yi SUN ; Zheng-Xue HAN ; Wei SHANG ; Jian MENG ; Zhong-Cheng GONG ; Sheng-Yun HUANG
West China Journal of Stomatology 2020;38(6):603-615
		                        		
		                        			
		                        			Large general hospitals currently play an increasingly important role in the diagnosis and treatment for acute critical patients and difficult diseases because of the development of dual referral system and hierarchical diagnosis, as well as the formation of medical treatment alliance. Patients with oral cancers are often associated with systemic diseases, which increases the complexity of the condition. Thus, meeting the demand through the traditional single medical model is difficult. As such, a multidisciplinary team (MDT) model has been proposed and has achieved a good clinical effect. To standardize the application of this model, we organized an event in which relevant experts discussed and formulated a consensus to provide standardized suggestions on the MDT process and the diagnosis and treatment of common systemic diseases as reference for clinical practice.
		                        		
		                        		
		                        		
		                        			Consensus
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Mouth Neoplasms/therapy*
		                        			;
		                        		
		                        			Patient Care Team
		                        			;
		                        		
		                        			Referral and Consultation
		                        			
		                        		
		                        	
8.Analysis of outcomes of randomized controlled trial on compound Chinese herbal medicine formulas in treatment of vascular cognitive impairment caused by cerebral small vessel.
Xin-Yang ZHANG ; Xing LIAO ; Xue-Mei LIU ; Ru-Yu XIA ; Xiao LIANG ; Zhen-Min XU ; Xi LI ; Nan-Nan LI ; Zhi-Gang CHEN
China Journal of Chinese Materia Medica 2020;45(23):5804-5818
		                        		
		                        			
		                        			The purpose of the study is to analyze the outcomes of randomized controlled trial(RCT) of Chinese herbal medicine formula(CHMF) in the treatment of vascular cognitive impairment caused by cerebral small vessel disease(CSVD-VCI), and provide suggestions for future studies in this field. Three English databases, four Chinese databases, and two online registration websites of clinical trials were searched with use of the search strategy established in advance. Relevant RCTs published in recent ten years were screened, and necessary information was extracted to assess the risk of bias and analyze the outcomes of these RCTs. As a result, a total of 10 461 articles were retrieved, of which 8 681 were kept after de-duplication, and 41 RCTs were included after screening, with a generally higher risk of bias. The outcomes of included RCTs were classified into 9 categories, namely, clinical symptom outcomes, neuroimaging outcomes, neuroelectrophysiological outcomes, blood biochemical outcomes, hemorheology outcomes, physical signs, syndrome scores of traditional Chinese medicine(TCM), clinical effective rate, and safety outcomes. Among them, the most frequently reported outcomes of included RCTs were blood biochemical outcomes, and clinical symptom outcomes showed the highest reporting rate. Besides, 9 RCTs reported syndrome scores of TCM as the outcomes and illustrated corresponding evaluation criteria. The analysis showed that the application of RCT outcomes in this field had clinical rationality and limitations, and there were also some deficiencies in the trial design level, namely, no distinction between primary and secondary outcomes, insufficient blind methods, not detailed description of outcomes, disunity of evaluation tools, and despised endpoint outcomes. These limitations and deficiencies were negatively affecting the quality of RCTs of CHMF in the treatment of CSVD-VCI. Therefore, we suggest that future researchers should be well prepared in the top-level design stage, and actively construct the core outcome set of this field, so as to improve the quality of clinical trials.
		                        		
		                        		
		                        		
		                        			Cerebral Small Vessel Diseases
		                        			;
		                        		
		                        			Cognitive Dysfunction
		                        			;
		                        		
		                        			Drugs, Chinese Herbal
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Medicine, Chinese Traditional
		                        			;
		                        		
		                        			Phytotherapy
		                        			
		                        		
		                        	
9.3, 4-seco-Labdane diterpenoids from the leaves of Callicarpa nudiflora with anti-inflammatory effects.
Hong-Gang WANG ; Fu-Kang LUO ; Xiang LEI ; Yun-Da YAO ; Guo-Chao LIAO ; Zhong-Qiu LIU ; Zhi-Hong JIANG ; Hua ZHOU ; Peng WU
Chinese Journal of Natural Medicines (English Ed.) 2019;17(9):707-712
		                        		
		                        			
		                        			Four new 3, 4-seco-labdane diterpenoids, nudiflopenes J-M, were isolated from the leaves of Callicarpa nudiflora along with six known compounds. The structures of these diterpenoids were determined by comprehensive spectroscopic analysis. All the isolated compounds were evaluated for their inhibitory effects on NO production in LPS-stimulated RPMs and RAW264.7 cells. The results suggest that nudiflopenes J-M and other four known compounds showed significant inhibitory effects against NO production comparable to the positive control dexamethasone.
		                        		
		                        		
		                        		
		                        	
10.Classification Tree Model Analysis on Risk Factors of Diabetic Kidney Disease to Progress to ESRD for CKD3-4 Stages Patients
Zhi-bo LIAO ; Xun LIU ; Cai-lian CHENG ; Cheng-gang SHI ; Shao-min LI ; Wen-bo ZHAO
Journal of Sun Yat-sen University(Medical Sciences) 2019;40(5):767-773
		                        		
		                        			
		                        			【Objective】To analyze the risk factors of progression to end-stage renal disease(ESRD)in patients with
diabetic kidney disease(DKD),and screen the high-risk population for early prevention.【Methods】The clinical data of
231 patients with diabetic nephropathy in our hospital were collected and followed up for 3 years. According to whether
ESRD occurred,they were divided into non-progressing ESRD group(133 cases)and ESRD group(98 cases). Classification
tree model was used to analyze the risk factors related to ESRD,and the high-risk population was screened by node gain
analysis.【Results】Four important explanatory variables were screened out by the classification tree model from the candi⁃
date variables related to early renal damage,including apolipoprotein B(ApoB),gender,diabetic retinopathy,systemic blood
pressure(SBP). ApoB level was an important factor for DKD progression. For DKD patients with the chronic kidney disease
(CKD)3~4 stageswith ApoB> 1.14 mmol/L,theprobabilityofprogression toESRDfor 3 yearswas 75.0 %,and ifat the same
time with diabetic retinopathy,the probability was 79.7 %.【Conclusion】The classification tree model can analyze the risk
factors of progression to ESRD in DKD patients effectively,to identify the characteristics of high-risk populations.
		                        		
		                        		
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail